Cargando…

Recombinant Toxoplasma gondii Ribosomal Protein P2 Modulates the Functions of Murine Macrophages In Vitro and Provides Immunity against Acute Toxoplasmosis In Vivo

Almost every warm-blooded animal can be an intermediate host for Toxoplasma gondii (T. gondii); there is still no efficient vaccine and medicine available for T. gondii infections. Detected on the surface of free tachyzoites of T. gondii, T. gondii ribosomal protein P2 (TgRPP2) has been identified a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Zhengqing, Lu, Yujia, Liu, Zhaoyi, Aleem, Muhammad Tahir, Liu, Junlong, Luo, Jianxun, Yan, Ruofeng, Xu, Lixin, Song, Xiaokai, Li, Xiangrui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068005/ https://www.ncbi.nlm.nih.gov/pubmed/33917244 http://dx.doi.org/10.3390/vaccines9040357

Ejemplares similares

Nano DNA Vaccine Encoding Toxoplasma gondii Histone Deacetylase SIR2 Enhanced Protective Immunity in Mice
por: Yu, Zhengqing, et al.
Publicado: (2021)

Toxoplasma gondii Proteasome Subunit Alpha Type 1 with Chitosan: A Promising Alternative to Traditional Adjuvant
por: Yu, Zhengqing, et al.
Publicado: (2021)

With Chitosan and PLGA as the Delivery Vehicle, Toxoplasma gondii Oxidoreductase-Based DNA Vaccines Decrease Parasite Burdens in Mice
por: Yu, Zhengqing, et al.
Publicado: (2021)

Nano vaccines for T. gondii Ribosomal P2 Protein With Nanomaterials as a Promising DNA Vaccine Against Toxoplasmosis
por: Yu, ZhengQing, et al.
Publicado: (2022)

Modulation Effects of Toxoplasma gondii Histone H2A1 on Murine Macrophages and Encapsulation with Polymer as a Vaccine Candidate
por: Yu, Zhengqing, et al.
Publicado: (2020)

Effects of Recombinant Toxoplasma gondii Citrate Synthase I on the Cellular Functions of Murine Macrophages In vitro
por: Liu, Xinchao, et al.
Publicado: (2017)

Toxoplasma gondii Elongation Factor 1-Alpha (TgEF-1α) Is a Novel Vaccine Candidate Antigen against Toxoplasmosis
por: Wang, Shuai, et al.
Publicado: (2017)

Toxoplasma gondii Histone 4 Affects Some Functions of Murine Ana‐1 Macrophages In Vitro
por: Liu, Xinchao, et al.
Publicado: (2018)

Protective immunity against acute toxoplasmosis in BALB/c mice induced by a DNA vaccine encoding Toxoplasma gondii elongation factor 1-alpha
por: Wang, Shuai, et al.
Publicado: (2015)

Diagnosis of toxoplasmosis and typing of Toxoplasma gondii
por: Liu, Quan, et al.
Publicado: (2015)

Toxoplasma gondii Recombinant Antigens in the Serodiagnosis of Toxoplasmosis in Domestic and Farm Animals
por: Ferra, Bartłomiej, et al.
Publicado: (2020)

Toxoplasma gondii excretory/secretory antigens (TgESAs) suppress pro-inflammatory cytokine secretion by inhibiting TLR-induced NF-κB activation in LPS-stimulated murine macrophages
por: Wang, Shuai, et al.
Publicado: (2017)

Proteomics analysis reveals that the proto-oncogene eIF-5A indirectly influences the growth, invasion and replication of Toxoplasma gondii tachyzoite
por: Liu, Xinchao, et al.
Publicado: (2021)

DNA vaccination with a gene encoding Toxoplasma gondii Deoxyribose Phosphate Aldolase (TgDPA) induces partial protective immunity against lethal challenge in mice
por: Hassan, Ibrahim A, et al.
Publicado: (2014)

Inhibition of Trichinella spiralis Membrane-Associated Progesterone Receptor (MAPR) Results in a Reduction in Worm Burden
por: Aleem, Muhammad Tahir, et al.
Publicado: (2023)

Vaccination against Murine Toxoplasmosis Using Recombinant Toxoplasma gondii SAG3 Antigen Alone or in Combination with Quil A
por: Lee, Young-Ha, et al.
Publicado: (2007)

Identification of Toxoplasma Gondii Tyrosine Hydroxylase (TH) Activity and Molecular Immunoprotection against Toxoplasmosis
por: Zhang, Zhenchao, et al.
Publicado: (2020)

Role of amylopectin synthesis in Toxoplasma gondii and its implication in vaccine development against toxoplasmosis
por: Lyu, Congcong, et al.
Publicado: (2021)

PLGA Nanospheres as Delivery Platforms for Eimeria mitis 1a Protein: A Novel Strategy to Improve Specific Immunity
por: Xu, Lixin, et al.
Publicado: (2022)

Intranasal Immunisation with Recombinant Toxoplasma gondii Actin Partly Protects Mice against Toxoplasmosis
por: Yin, Li-Tian, et al.
Publicado: (2013)

A Novel Vaccine Candidate: Recombinant Toxoplasma gondii Perforin-Like Protein 2 Stimulates Partial Protective Immunity Against Toxoplasmosis
por: Tian, Xiaowei, et al.
Publicado: (2022)

Eimeria maxima Rhomboid-like Protein 5 Provided Partial Protection against Homologous Challenge in Forms of Recombinant Protein and DNA Plasmid in Chickens
por: Tian, Di, et al.
Publicado: (2021)

Toxoplasma gondii α‐amylase deletion mutant is a promising vaccine against acute and chronic toxoplasmosis
por: Yang, Jing, et al.
Publicado: (2020)

Intranasal immunization with recombinant Toxoplasma gondii actin depolymerizing factor confers protective efficacy against toxoplasmosis in mice
por: Liu, Zhuanzhuan, et al.
Publicado: (2016)

Evaluation of toxoplasmosis in pregnant women using dot-immunogold-silver staining with recombinant Toxoplasma gondii peroxiredoxin protein
por: Liu, Zhuan-zhuan, et al.
Publicado: (2020)

Toxoplasma gondii infection and toxoplasmosis in North Africa: a review
por: Rouatbi, Mariem, et al.
Publicado: (2019)

Cloning and expression of Toxoplasma gondii GRA-4 recombinant protein as a toxoplasmosis diagnostic kit candidate
por: Hanafiah, Muhammad, et al.
Publicado: (2020)

Intranasal immunisation with recombinant Toxoplasma gondii uridine phosphorylase confers resistance against acute toxoplasmosis in mice
por: Yin, Li-Tian, et al.
Publicado: (2023)

Partial Protective Effect of Intranasal Immunization with Recombinant Toxoplasma gondii Rhoptry Protein 17 against Toxoplasmosis in Mice
por: Wang, Hai-Long, et al.
Publicado: (2014)

Genetic Divergence of Toxoplasma gondii Strains Associated with Ocular Toxoplasmosis, Brazil
por: Khan, Asis, et al.
Publicado: (2006)

Recombinant Toxoplasma gondii phosphoglycerate mutase 2 confers protective immunity against toxoplasmosis in BALB/c mice
por: Wang, Hai-Long, et al.
Publicado: (2016)

Severe Acquired Toxoplasmosis Caused by Wild Cycle of Toxoplasma gondii, French Guiana
por: Carme, Bernard, et al.
Publicado: (2009)

The role of DNA microarrays in Toxoplasma gondii research, the causative agent of ocular toxoplasmosis
por: Brown, Kevin M., et al.
Publicado: (2009)

Toxoplasma gondii cathepsin proteases are undeveloped prominent vaccine antigens against toxoplasmosis
por: Zhao, Guanghui, et al.
Publicado: (2013)

Effects of Toxoplasma gondii Infection in Level of Serum Testosterone in Males with Chronic Toxoplasmosis
por: ESLAMIRAD, Zahra, et al.
Publicado: (2013)

Genotyping of Toxoplasma gondii Strains Isolated from Patients with Ocular Toxoplasmosis in Iran
por: NOROUZI, Maryam, et al.
Publicado: (2016)

Targeting Toxoplasma gondii CPSF3 as a new approach to control toxoplasmosis
por: Palencia, Andrés, et al.
Publicado: (2017)

Experimental Porcine Toxoplasma gondii Infection as a Representative Model for Human Toxoplasmosis
por: Nau, Julia, et al.
Publicado: (2017)

Toxoplasma gondii infection and toxoplasmosis in farm animals: Risk factors and economic impact
por: Stelzer, S., et al.
Publicado: (2019)

Molecular Docking and In Silico Simulation of Trichinella spiralis Membrane-Associated Progesterone Receptor Component 2 (Ts-MAPRC2) and Its Interaction with Human PGRMC1
por: Aleem, Muhammad Tahir, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8m25q4uscoacls8kocqg67vm28